Seven Fleet discloses 80,000 Veradermics (MANE) shares in Form 3

Rhea-AI Filing Summary

Seven Fleet Capital Management LP, as a reporting person for Veradermics, Inc., has filed an initial Form 3 showing indirect ownership of 80,000 shares of common stock held by managed funds. The filing notes that Dr. Brian Liu may be deemed to control the reporting entities and may be deemed to beneficially own these shares, but he disclaims beneficial ownership except to the extent of any indirect pecuniary interest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Seven Fleet Capital Management LP

Role null

Type	Security	Shares	Price	Value
holding	Common Stock, $0.00001 par value per share	--	--	--

Holdings After Transaction: Common Stock, $0.00001 par value per share — 80,000 shares (Indirect, By Managed Funds)

Footnotes (1)

1. [object Object]

Key Figures

Indirect common shares held: 80,000 shares Par value per share: $0.00001 per share Form type: Form 3

3 metrics

Indirect common shares held 80,000 shares Total Veradermics common stock held indirectly by managed funds

Par value per share $0.00001 per share Par value of Veradermics common stock reported in the filing

Form type Form 3 Initial statement of beneficial ownership for a ten percent owner

Key Terms

Form 3, beneficially own, pecuniary interest, ten percent owner

4 terms

Form 3 regulatory

"This Form 3 is being filed by Seven Fleet Master Fund LP..."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficially own financial

"Dr. Liu may be deemed to control the Reporting Entities and therefore may be deemed to beneficially own shares..."

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

pecuniary interest financial

"Dr. Liu disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any indirect pecuniary interest therein."

ten percent owner regulatory

"Seven Fleet Capital Management LP is marked as a ten percent owner in the reportingPersons data."

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Seven Fleet Capital Management LP

(Last) (First) (Middle)

960 SAN CLEMENTE WAY

(Street)

MOUNTAIN VIEW CALIFORNIA 94043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026

3. Issuer Name and Ticker or Trading Symbol
Veradermics, Inc [ MANE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.00001 par value per share	80,000	I(1)	By Managed Funds(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This Form 3 is being filed by Seven Fleet Master Fund LP, a limited partnership organized under the laws of the Cayman Islands ("Seven Fleet Master Fund"), Seven Fleet Capital Management LP, a limited partnership organized under the laws of the State of Delaware ("Seven Fleet Management"), Seven Fleet Capital Management GP LLC, a limited liability company organized under the laws of the State of Delaware ("Seven Fleet Management GP" and together with Seven Fleet Master Fund and Seven Fleet Management, the "Reporting Entities") and Dr. Brian Liu. Dr. Liu may be deemed to control the Reporting Entities and therefore may be deemed to beneficially own shares of Common Stock held by the Reporting Entities. Dr. Liu disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any indirect pecuniary interest therein.

	Seven Fleet Master Fund LP By: Seven Fleet Capital Management LP, its Investment Manager By: Seven Fleet Capital Management GP, LLC, its General Partner /s/ Dr. Brian Liu Managing Member	05/05/2026
	Seven Fleet Capital Management LP By: Seven Fleet Capital Management GP, LLC, its General Partner /s/ Dr. Brian Liu Managing Member	05/05/2026
	Seven Fleet Capital Management GP LLC /s/ Dr. Brian Liu Managing Member	05/05/2026
	Brian Guan-Chyun Liu /s/ Dr. Brian Liu Managing Member	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Veradermics (MANE) disclose in this Form 3 filing?

Veradermics (MANE) reports that Seven Fleet Capital Management LP has filed a Form 3 showing indirect ownership of 80,000 shares of common stock through managed funds. This is an initial ownership report, not a buy or sell transaction.

How many Veradermics (MANE) shares are reported as owned by Seven Fleet?

The Form 3 shows Seven Fleet Capital Management LP indirectly holding 80,000 shares of Veradermics common stock through managed funds. This reflects the position after the reported holdings, establishing Seven Fleet as a significant shareholder and ten percent owner.

Is Dr. Brian Liu considered a beneficial owner of Veradermics (MANE) shares?

The filing states that Dr. Brian Liu may be deemed to control the reporting entities and thus may be deemed to beneficially own the Veradermics shares they hold. However, he disclaims beneficial ownership except for any indirect pecuniary interest he may have.

Are the Veradermics (MANE) shares held directly by Seven Fleet or through funds?

The 80,000 Veradermics shares are reported as held indirectly by Seven Fleet Capital Management LP "By Managed Funds." This means the position is through investment vehicles, not directly registered in Seven Fleet’s own name.

Does this Veradermics (MANE) Form 3 show any insider buying or selling?

No explicit buy or sell transactions are reported in this Form 3 for Veradermics (MANE). It is an initial statement of beneficial ownership showing an existing indirect holding of 80,000 common shares rather than new market trades.